baber/WOPTO huggingface dataset:
Patent EP-0591556-B1 (EP)
Inventor: KURITA SEIJI
IPC: B01F7/00
Filed: 1993-04-27
Granted: 1996-11-27
Abstract: Un procédé permet de produire un latex polymère en émulsifiant et en polymérisant un monomère polymère. Ce procédé se caractérise par le fait que la polymérisation intervient dans une cuve de polymérisation, laquelle se caractérise à son tour par: un arbre d'agitation (1), conçu pour être entraîné depuis l'extérieur de cette cuve, disposé dans la partie centrale de celle-ci et servant de support à une ailette inférieure (2) dotée d'un angle de flèche arrière α variant de 30° à 60° à son extrémité d'attaque, ailette placée dans la partie inférieure de la cuve, sa partie basse se trouvant proche de la surface inférieure de cette cuve d'agitation; une ailette plate (3), montée sur cet arbre d'agitation (1), au-dessus de l'ailette inférieure (2), présente un angle β, allant de 40° à 100°, entre son axe et celui de l'ailette inférieure et comprend une saillie inférieure plate (4) au bas de son extrémité d'attaque; plusieurs déflecteurs (5), placés dans le sens axial au long de la surface de la paroi latérale, dans cette cuve d'agitation, entre ses parties inférieure et supérieure, et disposés à certains intervalles. Le procédé utilisé permet de diminuer considérablement la quantité de substances solidifiées fines.
Patent EP-0639968-B1 (EP)
Inventor: HOFRICHTER BRIAN DAVID
IPC: A61K8/365
Filed: 1993-04-26
Granted: 1996-03-13
Abstract: An antiperspirant gel stick composition incorporating a gelling agent, including a primary gellant selected from the group consisting of 12-hydroxystearic acid, esters of 12-hydroxystearic acid, amides of 12-hydroxystearic acid, and mixtures thereof and a secondary gellant selected from the group consisting of n-acyl amino acid amide derivatives. The antiperspirant gel stick compositions further incorporate a liquid base material including a non-polar, volatile oil and a relatively polar, non-volatile co-solvent. The combination of the gelling agent and the co-solvent permit the utilization of relatively high levels of a non-polar volatile oils which provide a dry feel.
Patent EP-0649346-B1 (EP)
Inventor: FELDER ANTON
IPC: B01D21/24
Filed: 1993-06-03
Granted: 1998-11-11
Abstract: PCT No. PCT/EP93/01390 Sec. 371 Date Aug. 16, 1994 Sec. 102(e) Date Aug. 16, 1994 PCT Filed Jul. 21, 1993 PCT Pub. No. WO94/02251 PCT Pub. Date Feb. 3, 1994A device for centrically charging tanks (9) with a spin chamber (1, 10) connected to an inlet (20) and to a vertical downpipe (2, 12) ending seamlessly in a trumpet-shaped mouth (3, 18). Rotary flow charges circular settlement tanks and sand sorters and sedimentation tanks in such a way that the Coanda effect is activated at the trumpet-shaped mouth (3, 18) and in turn causes the rotary outflow of fluid from the vertical pipe (2, 12) to be diverted into the horizontal plane or vertically upwards as well as a radially symmetrical flow in the tank (9). There is a guiding pipe (14, 16) in the downpipe (2, 12) with preferably circular apertures around its periphery and which is open to the atmosphere at the top.
Patent EP-0655926-B1 (EP)
Inventor: GRUSS PETER
IPC: C12Q1/68
Filed: 1993-08-02
Granted: 1998-01-28
Abstract: PCT No. PCT/EP93/02051 Sec. 371 Date Mar. 27, 1995 Sec. 102(e) Date Mar. 27, 1995 PCT Filed Aug. 2, 1993 PCT Pub. No. WO94/03196 PCT Pub. Date Feb. 17, 1994A therapeutic or diagnostic agent according to the invention contains as the active substance at least one nucleic acid which hybridizes with a Pax gene or at least one Pax protein or at least one antibody against a Pax protein or a derivative thereof. The agents according to the invention are used in tumour diagnosis or/and tumour therapy as well as an antisense nucleic acid for the inhibition of gene expression.
Patent EP-0662946-B1 (EP)
Inventor: LINDNER NIGEL MALCOLM
IPC: A61K8/36
Filed: 1993-09-27
Granted: 1998-03-11
Abstract: PCT No. PCT/GB93/02006 Sec. 371 Date May 19, 1995 Sec. 102(e) Date May 19, 1995 PCT Filed Aug. 27, 1993 PCT Pub. No. WO94/07837 PCT Pub. Date Apr. 14, 1994Disclosed are certain novel polyunsaturated dioic acids having between 8 and 16 carbon atoms (inclusive), excluding those compounds in the group consisting of: 2,5 octadienedioic acid; 1,7 octadienedioic acid; 2,4,6 octatrienedioic acid; and 1,3,5,7 nonatetraenedioic acid; 2,5,8 decatrienedioic acid; 3,6 dodecadienedioic acid; 3,13 hexadecadienedioic acid. Also disclosed are pharmaceutical or cosmetic compositions comprising unsaturated dioic acids and certain of their derivatives. Also disclosed are methods of treating human skin and a method of preparing unsaturated dioic acids.
Patent EP-0642735-B1 (EP)
Inventor: EICKEN KARL DR
IPC: A01N37/38
Filed: 1994-09-03
Granted: 1997-06-04
Abstract: Fungicidal, synergistic mixture comprising     a) a compound of the formula I <IMAGE>  in which the substituents have the following meanings:   R<1> is a phenyl radical which can have attached to it one to three of the following groups: cyano, halogen, C1-C4-alkyl, C1-C2-haloalkyl and C1-C4-alkoxy, or a pyrimidyl radical which can have attached to it a C1-C3-alkyl group and/or a phenoxy group, it being possible for the phenoxy group, in turn, to have attached to it one to three of the following radicals: cyano, halogen, C1-C4-alkyl, C1-C2-haloalkyl and C1-C4-alkoxy,   A is oxygen or oxymethylene (-OCH2-);   X is CH or N, Y is oxygen or NR<2>, R<2> representing hydrogen, C1-C3-alkyl and C1-C3-alkoxy,  and   b) a pyrimidine derivative of the formula II <IMAGE>  in which R represents methyl, propyn-1-yl or cyclopropyl, in a synergistically effective amount.
Patent EP-0666046-B1 (EP)
Inventor: HEERIG HANS
IPC: A21B3/04
Filed: 1994-12-15
Granted: 2000-03-08
Abstract: In an assembly to apply heat treatment to food within a chamber (15), steam is generated (48) and introduced to the chamber (15) by pipe (54). Fluid is circulated within the chamber (15) by a blower (32), and steam entry is determined by a control unit (56) linked to a temperature sensor (72) and condensate (24) drain (22). The novelty is that the first temperature sensor (72) whose information is used to control the ingress of steam, is located within a sensor pipe (74), whose first end (41) is linked with the condensate drain pipe (24), and the second end (42) of which funnels into the blower (32) suction side (34).
Patent EP-0661162-B1 (EP)
Inventor: MORIYAMA JIRO
IPC: B41J2/175
Filed: 1994-12-27
Granted: 2000-07-12
Abstract: There is disclosed an ink-jet head for performing recording by discharging an ink, including a discharge port for discharging the ink, and an ink channel which communicates with the discharge port and is provided with a discharge energy generating element for discharging the ink. An optical element is arranged at a position, corresponding to the ink channel, of the ink-jet head. There are also disclosed an ink-jet apparatus using the ink-jet head and a substrate for the ink-jet head. <IMAGE>
Patent EP-0621560-B1 (EP)
Inventor: WEIJERS PETRUS MARINUS JOHANNE
IPC: G07C11/00
Filed: 1994-04-14
Granted: 1995-08-23
Abstract: Information-dispensing installation (1, 1') for supplying information to customers, at least provided with an information-dispensing unit (2) for issuing to the customers vouchers (59; 71, 72, 73) on which the said information is shown, which installation also comprises printer facilities (30, 31) for printing the information on the vouchers (59; 71, 72, 73), which printer facilities (30, 31) comprise at least a reprogrammable memory (34 or 35 or 36) for storing the information, and the installation (1, 1') being provided with input means (9, 12, 13, 14, 15), which can be coupled to the reprogrammable memory (34 or 35 or 36), for entering the information in the reprogrammable memory (34 or 35 or 36); in one embodiment the installation is suitable as a sequence number system. <IMAGE>
Patent EP-0650018-B1 (EP)
Inventor: ASHWORTH ROBERT A
IPC: F23J7/00
Filed: 1994-10-18
Granted: 1998-09-02
Abstract: First, nitrogen oxides are reduced by firing coal in substoichiometric air conditions in a first stage oxidation unit of a combustor to reduce NOx from fuel bound nitrogen. Hydrated lime, Ca(OH)2, is introduced into the first stage oxidation unit to produce calcium sulfide. The calcium sulfide becomes tied up in a slag eutectic which is removed prior to entry of the fuel gas to a second stage oxidation unit at the entrance of a furnace where additional preheated air is added to the fuel gas. <IMAGE>
Patent EP-0661408-B1 (EP)
Title: Multi-functional concrete girder
Inventor: MUELLER ANDREAS
IPC: E04B5/23
Filed: 1994-12-22
Granted: 1997-09-17
Abstract: In order to produce a building by the skeleton construction method, the invention proposes a multifunctional concrete girder (10) which comprises a longitudinal panel (11) with three parallel longitudinal ribs (12, 13, 14) connected integrally thereto. All the longitudinal ribs (12-14) are of the same height. An on-edge, relatively thin longitudinal rib (12) defines, together with a central, thickened longitudinal rib (13), a warm-air duct (15), while said thickened longitudinal rib (13) defines, together with a second longitudinal rib (14) which is offset inwardly from the other longitudinal border, a conduit (16). The remaining space on the surface of the longitudinal panel (11) forms a floor-beam rest (17). Floor beams made of any material may be rested on said floor-beam rest (17). The warm-air duct (15) is closed to the top by means of a plurality of covering panels (20). The covering panels (20) exhibit heat-conducting ribs (22) which project into the warm-air duct (15). By virtue of this design of multifunctional concrete girders, which, adjoining an installation tower of the building, run along the exterior building line, a building of the skeleton construction type can be subdivided in any manner at any time. This applies not only to areas in offices, commercial buildings or residential buildings, but also to the installation of bathroom units. <IMAGE>
Patent EP-0696983-B1 (EP)
Inventor: FLEMMING ROBERT J JR
IPC: B64C27/26
Filed: 1994-04-29
Granted: 1997-03-26
Abstract: Véhicule volant sans équipage (UAV) (100) possédant un fuselage toroïdal (120) et un ensemble rotor (170) comprenant des rotors contrarotatifs montés coaxialement par rapport au fuselage toroïdal. Cet engin incorpore des structures aérodynamiques auxiliaires (18) présentant un profil de plan de sustentation cambré produisant un moment de tangage piqué qui s'oppose au moment de tangage cabré produit par l'écoulement d'air sur le fuselage toroïdal pendant le vol en déplacement vers l'avant de l'UAV. Ces structures aérodynamiques auxiliaires sont montées de manière symétrique en combinaison avec les côtés latéraux du fuselage toroïdal, de sorte que les centres de la portance sont situés à l'arrière de l'axe du fuselage pendant le vol vers l'avant. Dans une première forme d'exécution, les structures aérodynamiques auxiliaires (18) sont montées fixes en combinaison avec le fuselage toroïdal (10) à un angle d'incidence prédéterminé. Dans une deuxième forme d'exécution, les structures aérodynamiques auxiliaires (19) sont montées rotatives en combinaison avec le fuselage toroïdal (10') afin de doter l'UAV de structures aérodynamiques auxiliaires à angle d'incidence variable.
Patent EP-0726772-B1 (EP)
Inventor: BARAL EDWARD
IPC: A61K35/14
Filed: 1994-08-02
Granted: 2001-11-07
Abstract: PCT No. PCT/FI94/00333 Sec. 371 Date Apr. 15, 1998 Sec. 102(e) Date Apr. 15, 1998 PCT Filed Aug. 2, 1994 PCT Pub. No. WO95/04544 PCT Pub. Date Feb. 16, 1995The invention relates to a method of sensitizing cancer cells for a killer cell mediated lysis which involves administering to a patient an effective amount of antiestrogen and killer cells either jointly or sequentially, wherein the killer cells are selected from the group of NK cells, LAK cells and CTL cells and the antiestrogen is selected from the group of triphenylethylene class antiestrogens, such as tamoxifen or toremifene or their pharmaceutically acceptable salt.
Patent EP-0705932-B1 (EP)
Inventor: JAMES WILLIAM A
IPC: D04H1/46
Filed: 1995-09-15
Granted: 2002-02-20
Abstract: Nonwoven fabrics having a fibrous background portion (12) in one plane thereof and raised fibrous portions (16; 18) in another plane thereof. There may be two types of raised portions (16; 18) in one type, the basis weight of the raised portion (16) is substantially the same as the basis weight of the background portion (12). In another type of raised portion (18), the basis weight is greater than the basis weight of the background portion (12). The raised portions (16; 18) are joined to the background portion (12) by a fibrous transition region (22; 24). <IMAGE>
Patent EP-0654360-B1 (EP)
Inventor: PARKER KEVIN P
IPC: B42C9/02
Filed: 1990-05-03
Granted: 1997-10-22
Abstract: Apparatus and method for binding a plurality of sheets arranged in a stack (36) utilizing a binding tape (32) is disclosed. Control means is provided for controlling the relative positions of the stack support means (44,46,104,76,84) and the platen means (112,114) to that the spine and cover seals can be formed. The control means includes measuring means (58,60) for measuring the thickness of the stack (36) to be bound and means for adjusting the spacing between the two support means (108,110,111,113;152) of the tape positioner means when the tape positioner means is in a tape load mode based upon the measured thickness. The tape positioner means accommodates one of the predetermined tape widths and fully supports the tape (32) during the tape load mode. <IMAGE>
Patent EP-0673005-B1 (EP)
Inventor: ORUS HERVE
IPC: G07F7/08
Filed: 1995-03-15
Granted: 1997-10-08
Abstract: The machine has the usual mechanical counters (101,106) and an electronic cash converter(121). The machine has control systems for cash out (122), cancel credit(123) cancel(124) and token input(106). The electronic cash converter controls the operation of the machines mechanical systems , so that when a valid credit card is inserted into the converter play can commence and a debit is taken from the credit card.
Patent EP-0718442-B1 (EP)
Inventor: TREVINATI ROMANO
IPC: E01F8/00
Filed: 1995-12-13
Granted: 1999-10-20
Abstract: A deadening barrier comprising an array of panels (P1,...,Pn), stacked and supported by fixed uprights (1) spaced from one another. Each panel comprises a first (3,23) and a second (7,22) containment sheet element having a substantially C-shaped section and facing each other, between which a layer (6,21) of material with high deadening coefficient is interposed. The containment element facing the noise source is uniformely perforated. The layer (6,21) is supported by first containment element (3,23) and second containment element (7,22) rests against the layer to hold it in position inside first containment element and support means (11,24) are provided for the second containment element and means (13,30) for blocking it between the support means and the panel support uprights. <IMAGE>
Patent EP-0734380-B1 (EP)
Inventor: BAILEY ANGELA JACQUELINE
IPC: A01N43/80
Filed: 1994-12-06
Granted: 2002-07-10
Abstract: Compound of the formulaare useful as intermediates to new 4-benzoylisoxazoles.
Patent EP-0740740-B1 (EP)
Inventor: GMELIN KARL
IPC: B29C45/14
Filed: 1994-12-09
Granted: 1999-04-14
Abstract: Des dispositif connus d'étranglement comprennent un clapet métallique d'étranglement monté par exemple dans une fente ménagée dans l'arbre de commande et rigidement assujetti par vissage à l'arbre de commande. La réalisation du clapet d'étranglement comme pièce séparée vissable entraîne, notamment lors de la production en série du dispositif d'étranglement des difficultés considérables de montage et des coûts élevés de production. Le dispositif d'étranglement décrit (1) comprend un organe d'étranglement (3) en matière plastique qui remplit de matière plastique une fente (20) ménagée dans l'arbre de commande (4) afin d'assurer la liaison rigide. Afin de produire l'organe d'étranglement (3), on introduit des outils d'injection (30, 31) dans un canal d'aspiration (10). Ces outils d'injection (30, 31), qui font eux aussi l'objet de l'invention, forment au moyen d'évidements (38, 39) une cavité en forme de clapet d'étranglement (3) lorsqu'ils s'appuient sur l'enveloppe extérieure (6) de l'arbre de commande. Le clapet d'étranglement (3) se forme lorsque cette cavité est remplie de matière plastique. Ce dispositif d'étranglement est particulièrement utile pour des moteurs à combustion interne à allumage par bougies et à compression du mélange ou pour des moteurs à combustion interne à allumage spontané et à compression d'air.
Patent EP-0733294-B1 (EP)
Inventor: STREATER STEPHEN BERNARD
IPC: H04N7/26
Filed: 1994-12-07
Granted: 2004-05-12
Abstract: PCT No. PCT/GB94/02683 Sec. 371 Date Aug. 29, 1996 Sec. 102(e) Date Aug. 29, 1996 PCT Filed Dec. 7, 1994 PCT Pub. No. WO95/16325 PCT Pub. Date Jun. 15, 1995A method of processing digital video information in real time involves reading-in digital data representing pixels of successive video frames, e.g., from a digitizer. The pixel frame data is initially stored and subjected to an idealization treatment to compare successive portions of the frame data to identify noise effects in the video image and to eliminate such effects. The idealized frame data is then subjected to compression by deriving further data representing blocks of pixels (mini-blocks) and blocks of mini-blocks (super-blocks) and by generating codewords of variable length to describe the changes in the pixel data of successive frames. The compressed data is finally stored and/or transmitted.
Patent EP-0755259-B1 (EP)
Inventor: VAKHARIA VIKRAM
IPC: A61K48/00
Filed: 1995-03-29
Granted: 2005-08-03
Abstract: Chimeric cDNA for the expression of immunogenic polypeptides include the genetic epitopic determinants for a base infectious bursal disease virus strain and at least one other infectious bursal disease virus strain. The genetic epitopic determinants encode amino acids or amino acid sequences which define epitopes bound to by previously established monoclonal antibodies. The immunogens expressed by the cDNA may be employed to provide a vaccine against a plurality of IBDV strains. The epitopic determinant of IBDV lethal strains has been detected, and an immunogen for conferring immunity with respect thereto is disclosed. Similarly, a monoclonal antibody specific for IBDV lethal strains is identified, and a vaccine for passive immunization therewith is also disclosed. Immunogens exhibiting conformational epitopes, in the form of virus-like particles, are effective in the preparation of vaccines.
Patent EP-0734411-B1 (EP)
Inventor: BAUER MONIKA
IPC: C08J11/28
Filed: 1995-09-07
Granted: 1999-04-14
Abstract: PCT No. PCT/DE95/01236 Sec. 371 Date Jun. 21, 1996 Sec. 102(e) Date Jun. 21, 1996 PCT Filed Sep. 7, 1995 PCT Pub. No. WO96/08530 PCT Pub. Date Mar. 21, 1996The invention concerns a method of decomposing materials containing polycyanurates, the method calling for the polycyanurate-containing materials to be converted, in a first operation, into a finely divided form and then, in a second operation, aminolysed with an agent containing at least one reactive NH2 group.
Patent EP-0784054-B1 (EP)
Inventor: SHISHIKURA JUN-ICHI
IPC: C07D403/04
Filed: 1995-09-25
Granted: 2001-11-28
Abstract: A 1,2,3,4-tetrahydroquinoxalinedione derivative represented by the following formula (I) or salt thereof, an NMDA-glycine receptor and/or AMPA receptor antagonist or kainic acid neurotoxicity inhibitor containing the derivative or salt. In addition, a pharmaceutical composition comprising said compound and a pharmaceutically acceptable carrier. <CHEM> wherein symbols in the above formula represent the following meanings, respectively:     X: N, CH,   R: an imidazolyl group or a di-lower alkylamino group,   R<1>:   (1) a halogen atom, a nitro group, a cyano group, a carboxyl group, an amino group, a mono- or di-lower alkylamino group, a lower alkanoyl group, a lower alkylthio group, a lower alkylsulfinyl group, a lower alkylsulfonyl group or a carbamoyl group, (2) a lower alkyl group or lower alkoxyl group which may be substituted by a halogen atom, a carboxyl group or an aryl group, (3) a phenyloxy group which may be substituted by a lower alkoxycarbonyl group or a carboxyl group,   R<2>: a hydroxyl group, a lower alkoxyl group, an amino group or a mono- or di-lower alkylamino group, A: a lower alkylene group which may be substituted or a group represented by the formula -O-B-, and   B: a lower alkylene group, with the proviso that the case wherein R represents an imidazolyl group, R<1> represents a cyano group, A represents an ethylene group and R<2> represents a hydroxyl group is excluded.
Patent EP-0804429-B1 (EP)
Inventor: KAPANEN MIKA
IPC: C07D307/60
Filed: 1995-10-04
Granted: 2004-03-17
Abstract: PCT No. PCT/FI95/00541 Sec. 371 Date Jun. 19, 1997 Sec. 102(e) Date Jun. 19, 1997 PCT Filed Oct. 4, 1995 PCT Pub. No. WO96/11193 PCT Pub. Date Apr. 18, 1996The invention relates to alkene-substituted cyclic carboxylic acid anhydrides which are formed from the reaction of a cyclic carboxylic acid anhydride, including succinic anhydride, and an olefin blend. The olefin blend is made up of internal linear and branched olefins and linear and/or branched  alpha -olefins, in which blend the olefins contain 13-25 carbon atoms. The alkene-substituted cyclic carboxylic acid anhydride can be used for the preparation of an ASA sizing agent suitable for paper sizing.
Patent EP-0789844-B1 (EP)
Inventor: ROSENBAUM JAN SUSAN
IPC: C12N15/00
Filed: 1995-10-30
Granted: 2002-02-06
Abstract: The present invention relates to a method for determining whether a compound is capable of binding to a BMP receptor kinase protein complex, the method comprising introducing a sample comprising the compound to the BMP receptor kinase protein complex and allowing the compound to bind to the BMP receptor kinase protein complex, wherein the BMP receptor kinase protein complex is comprised of a BMP type I receptor kinase protein and the BMP receptor kinase protein BRK-3. The invention further relates to a method for determining the concentration of a BMP receptor ligand in a clinical sample, the met-hod comprising introducing the sample comprising the ligand to a BMP receptor kinase protein complex and allowing the ligand to bind to the BMP receptor kinase protein complex, wherein the BMP receptor kinase protein complex is comprised of a BMP type I receptor kinase protein and BMP receptor kinase protein BRK-3. The invention further relates to a host cell co-transfected with an expression vector comprising a DNA sequence that codes for the BMP receptor kinase protein BRK-3 and an expression vector comprising a DNA sequence that codes for a BMP type I receptor kinase protein. The invention further relates to a host cell co-transfected with an expression vector comprising a DNA sequence that codes for a soluble or incomplete BMP type I receptor kinase protein and a soluble or incomplete BMP receptor kinsase protein BRK-3. The invention further relates to a method for determining whether a test compound produces a signal upon binding to a BMP receptor protein complex.
Patent EP-0781591-B1 (EP)
Inventor: SHIRAISHI EIICHI
IPC: B01J37/02
Filed: 1996-12-27
Granted: 2006-12-27
Abstract: A purifying catalyst for the exhaust gas from the internal combustion engine of an automobile, for example, is disclosed which excels in the purifying ability in quick response to the atmosphere of the exhaust gas largely varying with changes in the operating condition of the engine involving such phases as idling, acceleration, constant-speed drive, and deceleration. The purifying catalyst contains rhodium, palladium, a cerium compound, and a refractory inorganic oxide as catalytic components carried on a refractory carrier and comprises at least two catalyst layers, namely a catalyst layer containing the cerium compound and a catalyst layer containing palladium.